Utility of line probe assay for the early detection of multidrug-resistant pulmonary tuberculosis

Journal of Global Infectious Diseases

Volumn 7, Issue 2, 2015, Pages 60-65

  Madhuri, K ^a   Deshpande, Smita ^a   Dharmashale, Sujata ^a   Bharadwaj, Renu ^a  

^a B J Government Medical College   (India)

Author keywords

Genotype MTBDR plus; heteroresistance; multidrug resistance; pulmonary tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA EXTRACTION; EARLY DIAGNOSIS; HUMAN; LINE PROBE ASSAY; LUNG LAVAGE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT EXAMINATION; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM CULTURE;

EID: 84930438144     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.157237     Document Type: Article

References (23)

1. Govt of India. TB India 2012, Revised National TB Control Program, Annual Status Report-Central TB Division; Directorate General of Health Services, New Delhi. Available from: http://www.tbcindia.org. [Last accessed on 2012 Jun 25].
2. Ajbani K, Shetty A, Mehta A, Rodrigues C. Rapid diagnosis of drug resistant tuberculosis by use of Reverse Line Blot Hybridisation Assay. J Clin Microbiol 2011;49:2546-51.
3. Abdelaal A, El-Ghaffar HA, Zaghloul MH, El Mashad N, Badran E, Fathy A. Genotypic detection of rifampicin and isoniazid resistance in M.tuberculosis by DNA sequencing: A randomised trial. Ann Clin Microbiol Antimicrobiol 2009;8:4.
4. World Health Organisation: Policy statement. Molecular Line Probe Assays for Rapid Screening of patients at risk of multidrug resistant tuberculosis (MDR-TB); 2008.
5. Pradhan N, Desai S, Kagal A, Dharmashale S, Bharadwaj R, Ghorpade S, et al. Patterns of TB Drug-Resistance in a tertiary care facility in Pune, India. Clin Microbiol 2013, 2:123.
6. Available from: http://www.tbcindia.nic.in/pdfs/Training%20manual%20M%20tuberculosis%20C%20DST.pdf [Last accessed on 2012 Jan 12].
7. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92.
8. Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, et al. Validation of the Genotype MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis 2010;10:149.
9. Raveendran R, Wattal C, Oberoi JK, Goel N, Datta S, Prasad KJ. Utility of Genotype MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India. Indian J Med Microbiol 2012;30:58-63.
10. Mäkinen J, Marttila HJ, Marjamäki M, Viljanen MK, Soini H. Comparision of Two Commercially Available DNA Line probe assays for the detection of Multidrug-Resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44:350-2.
11. Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A, Kreiswirth BN, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994;32:1095-8.
12. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR Assay for Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolates. J Clin Microbiol 2006;44:2338-42.
13. Parsons LM, Somoskövi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, et al. Laboratory diagnosis of tuberculosis in resource-poor countries, challenges and opportunities. Clin Microbiol Rev 2011;24:314-50.
14. Zhang L, Ye Y, Duo L, Wang T, Song X, Lu X, et al. Application of Genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China. Mol Biol Rep 2011;38:2185-92.
15. Vijdea R, Stegger M, Sosnovskaja A, Andersen AB, Thomsen VØ, Bang D. Multidrug-resistant tuberculosis: Rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates. Eur J Clin Microbiol Infect Dis 2008;27:1079-86.
16. Mokrousov I, Narvskaya O, Otten T, Limenschenko E, Steklova L, Vyshnevskiy B. High prevalence of katG Ser315Thr substitution among isoniazid resistant Mycobacterium tuberculosis isolates from Northwestern Russia, 1996-2001. Antimicrob Agents Chemother 2002;46:1417-24.
17. Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, et al. Cepheid GeneXpert MTB/RIF Assay for Mycobacterium tuberculosis Detection and Rifampin Resistance Identification in Patients with Substantial Clinical Indications of Tuberculosis and Smear-Negative Microscopy Results. J Clin Microbiol 2011;49:3068-78.
18. Vadwai V, Boehme C, Nabeta P, Shetty A, Rodrigues C. Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases. Indian J Med Res 2012;135:560-1.
19. Tolani MP, D'souza DT, Mistry NF. Drug resistance mutations and heteroresistance detected using the GenoType MTBDR plus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect Dis 2012;12:9.
20. Hauck Y, Fabre M, Vergnaud G, Soler C, Pourcel C. Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. J Antimicrob Chemother 2009;64:259-62.
21. Cavusoglu C, Gursel D, Aktoprak H. Evaluation of the genotype MTBDR plus assay for the diagnosis of tuberculosis and rapid detection of rifampin and isoniazid resistance in clinical specimens. Turk J Med Sci 2011;41:419-25.
22. Rinder H. Hetero-resistance: An under-recognised confounder in diagnosis and therapy. J Med Microbiol 2001;50:1018-20.
23. Hofmann-Thiel S, van Ingen J, Feldmann K, Turaev L, Uzakova GT, Murmusaeva G, et al. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur Respir J 2009;33:368-74.